With Medicare’s annual enrollment period starting this week, Louisianans who qualify for both Medicare and Medicaid are encouraged to explore health plans to combine benefits. Dual Eligible Special ...

The Office of Management and Budget issued reduction in force notices to Treasury staff working in the Community Development ...

This month's first round of disability payments will be dispersed this week. Here's how your date of birth determines when ...

In June 2025, the FDA granted priority review to the sNDA of revumenib (Revuforj) in relapsed/refractory NPM1 -mutant acute ...

The FDA is expected to decide on treatments for acute myeloid leukemia, chronic rhinosinusitis with nasal polyps, lupus nephritis, pediatric myopia, and small-cell lung cancer.

Navigating the Supplemental Nutrition Assistance Program (SNAP) can be complex, especially for seniors and individuals with disabilities. Understanding the updated eligibility criteria is crucial, as ...

If approved, ZORYVE cream would be the first and only topical PDE4 inhibitor indicated for plaque psoriasis in children as young as 2, offering patients and caregivers an important alternative to ...

LEQEMBI IQLIK, if approved for initiation dosing, would be the first and only anti-amyloid treatment to offer at-home injection from the start to help patients and care partners treat this progressive ...

TOKYO and CAMBRIDGE, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB ...

In order to be considered for transfer admission to UB, we recommend that students present a strong record of college study, with a cumulative grade point average of at least 2.5 on a 4.0 scale. It ...

Bristol Myers Squibb (NYSE:BMY) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application (sNDA) for Sotyktu (deucravacitinib) for ...